Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - MONSANTO CO /NEW/ | form8k.htm |
Monsanto Company
800 North Lindbergh Blvd
St. Louis, Missouri 63167
|
Release
|
Immediately
|
|
Contact
|
Media: Sara Miller (314-694-5824)
|
|
Analysts: Bryan Hurley (314-694-8148)
|
STRENGTH ACROSS MONSANTO COMPANY BUSINESS PORTFOLIO DRIVES FIRST QUARTER RESULTS AND MOMENTUM AS COMPANY INCREASES FULL YEAR GUIDANCE
|
·
|
Company Raises Full-Year Ongoing Earnings Per Share Guidance to $4.30 to $4.40, or $4.31 to $4.41 As-Reported, Increases Free Cash Flow Guidance
|
|
·
|
Positive Early Order Book in U.S. Shows Strong Business Momentum
|
|
·
|
Record Number of Projects Advance in R&D Platforms, Reinforcing Industry-Leading Pipeline
|
ST. LOUIS, Jan. 8, 2013 – Monsanto Company (NYSE: MON) delivered strong results for the first quarter of its fiscal year 2013, reflecting contributions from the continued expansion of its Latin American corn business, early momentum in its U.S. seeds and traits business and performance of its agricultural productivity segment. Executives said the cumulative strength of the company’s broad business portfolio translated to an increase in full-year earnings per share and free cash flow guidance, even at this early point in the company’s fiscal year. Monsanto also highlighted 18 phase advancements across its integrated yield pipeline, a record for its annual research and development update.
|
($ in millions)
|
First Quarter
2013
|
First Quarter
2012
|
||||||
|
Net Sales By Segment
|
||||||||
|
Corn seed and traits
|
$ | 1,139 | $ | 895 | ||||
|
Soybean seed and traits
|
231 | 242 | ||||||
|
Cotton seed and traits
|
185 | 194 | ||||||
|
Vegetable seeds
|
156 | 157 | ||||||
|
All other crops seeds and traits
|
44 | 46 | ||||||
|
TOTAL Seeds and Genomics
|
$ | 1,755 | $ | 1,534 | ||||
|
Agricultural Productivity
|
1,184 | 905 | ||||||
|
TOTAL Agricultural Productivity
|
$ | 1,184 | $ | 905 | ||||
|
TOTAL Net Sales
|
$ | 2,939 | $ | 2,439 | ||||
|
Gross Profit
|
$ | 1,397 | $ | 1,096 | ||||
|
Operating Expenses
|
$ | 888 | $ | 851 | ||||
|
Interest Expense – Net
|
$ | 28 | $ | 35 | ||||
|
Other Expense – Net
|
$ | 17 | $ | 6 | ||||
|
Net Income Attributable to Monsanto Company
|
$ | 339 | $ | 126 | ||||
|
Diluted Earnings per Share (See note 1.)
|
$ | 0.63 | $ | 0.23 | ||||
|
Items Affecting Comparability – EPS Impact
|
||||||||
|
Income on discontinued operations
|
$ | (0.01 | ) | $ | — | |||
|
Diluted Earnings per Share from Ongoing Business (For the definition of ongoing
EPS, see note 1.)
|
$ | 0.62 | $ | 0.23 | ||||
|
Effective Tax Rate
|
26 | % | 34 | % | ||||
|
Comparison as a Percent of Net Sales:
|
First Quarter
2013
|
First Quarter
2012
|
||||
|
Gross profit
|
48
|
%
|
45
|
%
|
||
|
Selling, general and administrative expenses
|
18
|
%
|
21
|
%
|
||
|
Research and development expenses
|
12
|
%
|
14
|
%
|
||
|
Income before income taxes
|
16
|
%
|
8
|
%
|
||
|
Net Income Attributable to Monsanto Company
|
12
|
%
|
5
|
%
|
||
“We’ve achieved a successful start to the year, with contributions from multiple areas that speaks to the strength of our global business and provides confidence in our ability to realize a third consecutive year of significant growth,” said Hugh Grant, chairman and chief executive officer for Monsanto. “The momentum in our business is also seen in our record research and development progress. Through continued innovation in our integrated yield pipeline, we remain committed to delivering cutting-edge solutions that will bring additional value to our customers.”
Results of Operations
The company achieved strong first quarter results that reflect the strength and growth of its business. Net sales for the quarter increased 21 percent over the prior year’s first quarter to $2.9 billion, with significant contribution from the corn seed and traits business, led by the corn opportunity acceleration in Latin America and strong shipments in the United States reflective of a positive order book. Gross profit for the 2013 first quarter increased 27 percent over the prior year period to $1.4 billion.
Selling, general and administrative (SG&A) costs were $542 million in the first quarter. Research and development (R&D) expenses decreased year-over-year to $346 million for the quarter.
The company’s first quarter earnings per share (EPS) was $0.62 on an ongoing and $0.63 on an as-reported basis. (For a reconciliation of ongoing EPS, see note 1.)
Cash Flow
The higher first quarter business results are also reflected in the company’s free cash flow, which was a source of $1.5 billion compared with a source of $856 million for the prior year first quarter. (For a reconciliation of free cash flow, see note 1.) The raise reflects an increase in customer prepayments in advance of the U.S. season combined with the translation of increased earnings into cash.
Net cash provided by operating activities for the 2013 fiscal year first quarter was a source of $1.6 billion, compared to a source of $1.1 billion in the first quarter last year. Net cash required by investing activities for the first quarter of 2013 was $96 million, compared with $254 million for the same period of fiscal year 2012. Net cash required by financing activities for the first quarter of 2013 was $116 million, compared with $340 million for the prior year’s first quarter.
Outlook
The company raised its full year ongoing EPS guidance to $4.30 to $4.40 per share, positioning the company for a third straight year of strong ongoing earnings growth. Full-year 2013 EPS guidance on an as-reported basis is expected in the range of $4.31 to $4.41 per share. (For a reconciliation of EPS, see note 1.)
The company also raised full year free cash flow guidance to $1.8 billion to $2 billion. The company expects net cash provided by operating activities to be $2.9 billion to $3.3 billion, and net cash required by investing activities to be $1.1 billion to $1.3 billion for fiscal year 2013. (For a reconciliation of free cash flow, see note 1.)
The updated EPS and free cash flow guidance does not include an estimated historical range of $0.20 to $0.25 of EPS contribution related to the Roundup Ready soybean business in Brazil given uncertainty in timing of resolution of ongoing business and legal developments.
Seeds and Genomics Segment Detail
|
($ in millions)
|
Net Sales
|
Gross Profit
|
||||||||
|
Seeds and Genomics
|
First
Quarter
2013
|
First
Quarter
2012
|
First
Quarter
2013
|
First
Quarter
2012
|
||||||
|
Corn seed and traits
|
$
|
1,139
|
$
|
895
|
$
|
686
|
$
|
531
|
||
|
Soybean seed and traits
|
231
|
242
|
118
|
173
|
||||||
|
Cotton seed and traits
|
185
|
194
|
127
|
135
|
||||||
|
Vegetable seeds
|
156
|
157
|
83
|
81
|
||||||
|
All other crops seeds and traits
|
44
|
46
|
11
|
(4)
|
||||||
|
TOTAL Seeds and Genomics
|
$
|
1,755
|
$
|
1,534
|
$
|
1,025
|
$
|
916
|
||
|
($ in millions)
|
Earnings Before Interest &
Taxes (EBIT)
|
|||||
|
Seeds and Genomics
|
First
Quarter
2013
|
First
Quarter
2012
|
||||
|
EBIT (For a reconciliation of EBIT, see note 1.)
|
$
|
220
|
$
|
147
|
||
The Seeds and Genomics segment consists of the company’s global seeds and related traits business.
Sales for Monsanto’s Seeds and Genomics segment increased 14 percent in the first quarter to $1.8 billion, with corn seed and traits performance driving the first quarter strength.
Corn seed and traits net sales increased 27 percent over last year’s first quarter to $1.1 billion, driven in part by the business strength in Brazil, Argentina and Mexico. The trait upgrade and expansion is on track in both Brazil and Argentina where the company is achieving strong demand for its corn products. In Brazil, farmers continue to upgrade from single trait corn products to the first double stack, VT PRO™ 2. In its second year of commercial sales, VT PRO™ 2 is the second-highest volume trait in the company’s Brazil corn portfolio this year. Likewise, in Argentina, the company has also seen strong adoption of its Genuity® VT Triple PRO® product. The triple-stack corn product is on track to be 40 percent of the company’s Argentine corn portfolio in just its second year on the market.
Complementing the corn performance in Latin America is the early momentum in the U.S. seeds and traits business. Backed by strong cash flow and customer prepayments, the company noted a positive U.S. order book, with the order pace ahead of the same point in time last year. With two years of strong performance, company executives said the U.S. business is in position to grow again in 2013. This includes another increase in acres for both its Genuity® Roundup Ready 2 Yield® platform in soybeans and the Genuity® reduced refuge family in corn.
Agricultural Productivity Segment Detail
|
($ in millions)
|
Net Sales
|
Gross Profit
|
||||||||
|
Agricultural Productivity
|
First
Quarter
2013
|
First
Quarter
2012
|
First
Quarter
2013
|
First
Quarter
2012
|
||||||
|
TOTAL Agricultural Productivity
|
$
|
1,184
|
$
|
905
|
$
|
372
|
$
|
180
|
||
|
($ in millions)
|
Earnings Before Interest & Taxes
(EBIT)
|
||||||
|
Agricultural Productivity
|
First
Quarter
2013
|
First
Quarter
2012
|
|||||
|
EBIT (For a reconciliation of EBIT, see note 1.)
|
$
|
270
|
$
|
82
|
|||
|
Unusual Items Affecting EBIT: Discontinued Operations
|
$
|
11
|
$
|
—
|
|||
The Agricultural Productivity segment consists of the crop protection products and lawn-and-garden herbicide products.
Net sales in the first quarter of fiscal 2013 for Monsanto’s Agricultural Productivity segment increased $279 million, reflecting the benefit of a favorable marketplace environment lifting the business in the near-term. The company indicated it remains focused on its established strategy for Roundup® following the reset of that business in 2010.
Webcast Information
In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central time (9:30 a.m. eastern time) today. The call will focus on these results, future expectations and an update of projects within the company’s R&D pipeline. The call also may include a discussion of Monsanto’s strategic initiatives, product performance and other matters related to the company’s business.
Presentation slides and a simultaneous audio webcast of the conference call may be accessed by visiting the company’s web site at www.monsanto.com/investors or by visiting
http://edge.media-server.com/m/p/5866v2f7/lan/en. Visitors may need to download Windows Media Player™ prior to listening to the webcast. Following the live broadcast, a replay of the webcast will be available on the Monsanto Web site for three weeks.
About Monsanto Company
Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com. Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at www.monsantoblog.com, or subscribe to our News Release RSS Feed.
Cautionary Statements Regarding Forward-Looking Information:
Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among
others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits and the previously-announced SEC investigation; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent Form 10-K Report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.
Notes to editors: Monsanto and the Vine Design, VT Triple PRO, VT PRO 2, Genuity, Roundup and Roundup Ready 2 Yield are trademarks of Monsanto Company and its wholly-owned subsidiaries.
-oOo-
Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
|
Statements of Consolidated Operations
|
Three Months Ended
|
|||||||
|
Nov. 30,
|
||||||||
|
2012
|
2011
|
|||||||
|
Net Sales
|
$ | 2,939 | $ | 2,439 | ||||
|
Cost of Goods Sold
|
1,542 | 1,343 | ||||||
|
Gross Profit
|
1,397 | 1,096 | ||||||
|
Operating Expenses:
|
||||||||
|
Selling, General and Administrative Expenses
|
542 | 500 | ||||||
|
Research and Development Expenses
|
346 | 351 | ||||||
|
Total Operating Expenses
|
888 | 851 | ||||||
|
Income From Operations
|
509 | 245 | ||||||
|
Interest Expense
|
51 | 53 | ||||||
|
Interest Income
|
(23 | ) | (18 | ) | ||||
|
Other Expense, Net
|
17 | 6 | ||||||
|
Income Before Income Taxes
|
464 | 204 | ||||||
|
Income Tax Provision
|
122 | 70 | ||||||
|
Income from Continuing Operations Including Portion Attributable
|
||||||||
|
to Noncontrolling Interest
|
$ | 342 | $ | 134 | ||||
|
Discontinued Operations:
|
||||||||
|
Income from Operations of Discontinued Businesses
|
11 | — | ||||||
|
Income Tax Provision
|
4 | — | ||||||
|
Income on Discontinued Operations
|
7 | — | ||||||
|
Net Income Including Portion Attributable to Noncontrolling Interest
|
$ | 349 | $ | 134 | ||||
|
Less: Net Income Attributable to Noncontrolling Interest
|
10 | 8 | ||||||
|
Net Income Attributable to Monsanto Company
|
$ | 339 | $ | 126 | ||||
|
EBIT (see note 1)
|
$ | 490 | $ | 229 | ||||
|
Basic Earnings per Share:
|
||||||||
|
Income from Continuing Operations
|
$ | 0.62 | $ | 0.24 | ||||
|
Income on Discontinued Operations
|
0.01 | — | ||||||
|
Basic Earnings per Share Attributable to Monsanto Company
|
$ | 0.63 | $ | 0.24 | ||||
|
Diluted Earnings per Share:
|
||||||||
|
Income from Continuing Operations
|
$ | 0.62 | $ | 0.23 | ||||
|
Income on Discontinued Operations
|
0.01 | — | ||||||
|
Diluted Earnings per Share Attributable to Monsanto Company
|
$ | 0.63 | $ | 0.23 | ||||
|
Weighted Average Shares Outstanding:
|
||||||||
|
Basic
|
534.8 | 535.4 | ||||||
|
Diluted
|
540.4 | 541.4 | ||||||
Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
|
Condensed Statements of Consolidated Financial Position
|
As of
|
As of
|
||||||
|
Nov. 30, 2012
|
Aug. 31, 2012
|
|||||||
|
Assets
|
||||||||
|
Current Assets:
|
||||||||
|
Cash and cash equivalents (variable interest entity restricted - 2013: $30 and 2012: $120)
|
$ | 4,637 | $ | 3,283 | ||||
|
Short-term investments
|
310 | 302 | ||||||
|
Trade Receivables, net (variable interest entity restricted - 2013: $140 and 2012: $52)
|
2,168 | 1,897 | ||||||
|
Miscellaneous Receivables
|
700 | 620 | ||||||
|
Deferred Tax Assets
|
513 | 534 | ||||||
|
Inventory, Net
|
3,571 | 2,839 | ||||||
|
Other Current Assets (variable interest entity restricted - 2013: $2)
|
161 | 183 | ||||||
|
Total Current Assets
|
12,060 | 9,658 | ||||||
|
Property, Plant and Equipment, Net
|
4,348 | 4,365 | ||||||
|
Goodwill
|
3,447 | 3,435 | ||||||
|
Other Intangible Assets, Net
|
1,210 | 1,237 | ||||||
|
Noncurrent Deferred Tax Assets
|
552 | 551 | ||||||
|
Long-Term Receivables, Net
|
290 | 376 | ||||||
|
Other Assets
|
630 | 602 | ||||||
|
Total Assets
|
$ | 22,537 | $ | 20,224 | ||||
|
Liabilities and Shareowners’ Equity
|
||||||||
|
Current Liabilities:
|
||||||||
|
Short-Term Debt, Including Current Portion of Long-Term Debt
|
$ | 26 | $ | 36 | ||||
|
Accounts Payable
|
785 | 794 | ||||||
|
Income Taxes Payable
|
68 | 75 | ||||||
|
Accrued Compensation and Benefits
|
307 | 546 | ||||||
|
Accrued Marketing Programs
|
710 | 1,281 | ||||||
|
Deferred Revenues
|
2,843 | 396 | ||||||
|
Grower Production Accruals
|
711 | 194 | ||||||
|
Dividends Payable
|
— | 200 | ||||||
|
Customer Payable
|
8 | 14 | ||||||
|
Miscellaneous Short-Term Accruals
|
703 | 685 | ||||||
|
Total Current Liabilities
|
6,161 | 4,221 | ||||||
|
Long-Term Debt
|
2,054 | 2,038 | ||||||
|
Postretirement Liabilities
|
530 | 543 | ||||||
|
Long-Term Deferred Revenue
|
218 | 245 | ||||||
|
Noncurrent Deferred Tax Liabilities
|
314 | 313 | ||||||
|
Long-Term Portion of Environmental and Litigation Reserves
|
212 | 213 | ||||||
|
Other Liabilities
|
583 | 615 | ||||||
|
Monsanto Shareowners’ Equity
|
12,259 | 11,833 | ||||||
|
Noncontrolling Interest
|
206 | 203 | ||||||
|
Total Shareowners’ Equity
|
12,465 | 12,036 | ||||||
|
Total Liabilities and Shareowners’ Equity
|
$ | 22,537 | $ | 20,224 | ||||
|
Debt to Capital Ratio:
|
15 | % | 15 | % | ||||
Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
|
Statements of Consolidated Cash Flows
|
Three Months Ended
|
|||||||
|
Nov. 30,
|
||||||||
|
2012
|
2011
|
|||||||
|
Operating Activities:
|
||||||||
|
Net Income
|
$ | 349 | $ | 134 | ||||
|
Adjustments to Reconcile Cash Provided by Operating Activities:
|
||||||||
|
Items That Did Not Require (Provide) Cash:
|
||||||||
|
Depreciation and Amortization
|
152 | 155 | ||||||
|
Bad-Debt Expense
|
7 | (1 | ) | |||||
|
Stock-Based Compensation Expense
|
24 | 23 | ||||||
|
Excess Tax Benefits from Stock-Based Compensation
|
(15 | ) | (6 | ) | ||||
|
Deferred Income Taxes
|
10 | (48 | ) | |||||
|
Equity Affiliate (Income) Expense, Net
|
(2 | ) | 1 | |||||
|
Net Gain on Sales of a Business or Other Assets
|
(12 | ) | (1 | ) | ||||
|
Other Items
|
(24 | ) | (55 | ) | ||||
|
Changes in Assets and Liabilities that (Required) Provided Cash, Net of Acquisitions:
|
||||||||
|
Trade Receivables, Net
|
(219 | ) | 49 | |||||
|
Inventory, Net
|
(754 | ) | (679 | ) | ||||
|
Deferred Revenues
|
2,422 | 1,624 | ||||||
|
Accounts Payable and Other Accrued Liabilities
|
(398 | ) | (127 | ) | ||||
|
Restructuring Cash Payments
|
— | (4 | ) | |||||
|
Pension Contributions
|
(16 | ) | (5 | ) | ||||
|
Other Items
|
45 | 50 | ||||||
|
Net Cash Provided by Operating Activities
|
1,569 | 1,110 | ||||||
|
Cash Flows (Required) Provided by Investing Activities:
|
||||||||
|
Purchases of Short-Term Investments
|
(118 | ) | (142 | ) | ||||
|
Maturities of Short-Term Investments
|
110 | 142 | ||||||
|
Capital Expenditures
|
(133 | ) | (138 | ) | ||||
|
Acquisitions of Businesses, Net of Cash Acquired
|
— | (113 | ) | |||||
|
Technology and Other Investments
|
(23 | ) | (5 | ) | ||||
|
Other Proceeds
|
68 | 2 | ||||||
|
Net Cash Required by Investing Activities
|
(96 | ) | (254 | ) | ||||
|
Cash Flows Provided (Required) by Financing Activities:
|
||||||||
|
Net Change in Financing With Less Than 90-Day Maturities
|
60 | (8 | ) | |||||
|
Short-Term Debt Reductions
|
(7 | ) | (17 | ) | ||||
|
Long-Term Debt Proceeds
|
16 | 1 | ||||||
|
Long-Term Debt Reductions
|
— | (138 | ) | |||||
|
Treasury Stock Purchases
|
(27 | ) | (26 | ) | ||||
|
Stock Option Exercises
|
31 | 12 | ||||||
|
Excess Tax Benefits from Stock-Based Compensation
|
16 | 6 | ||||||
|
Tax Withholding on Restricted Stock and Restricted Stock Units
|
(3 | ) | (1 | ) | ||||
|
Dividend Payments
|
(201 | ) | (161 | ) | ||||
|
Dividend Payments to Noncontrolling Interests
|
(1 | ) | (8 | ) | ||||
|
Net Cash Required by Financing Activities
|
(116 | ) | (340 | ) | ||||
|
Effect of Exchange Rate Changes on Cash and Cash Equivalents
|
(3 | ) | (81 | ) | ||||
|
Net Increase in Cash and Cash Equivalents
|
1,354 | 435 | ||||||
|
Cash and Cash Equivalents at Beginning of Period
|
3,283 | 2,572 | ||||||
|
Cash and Cash Equivalents at End of Period
|
$ | 4,637 | $ | 3,007 | ||||
Monsanto Company
Selected Financial Information
(Dollars in millions)
Unaudited
|
1.
|
EBIT, Ongoing EPS and Free Cash Flow: The presentations of EBIT, ongoing EPS and free cash flow are not intended to replace net income attributable to Monsanto Company, cash flows, financial position or comprehensive income (loss), and they are not measures of financial performance as determined in accordance with generally accepted accounting principles (GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS and free cash flow to the respective most directly comparable financial measure calculated in accordance with GAAP.
|
Reconciliation of EBIT to Net Income: EBIT is defined as earnings before interest and taxes. Earnings is intended to mean net income attributable to Monsanto Company as presented in the Statements of Consolidated Operations under GAAP. The following table reconciles EBIT to the most directly comparable financial measure, which is net income attributable to Monsanto.
|
Three Months Ended
|
|||||
|
Nov. 30,
|
|||||
|
2012
|
2011
|
||||
|
EBIT – Seeds and Genomics Segment
|
$
|
220
|
$
|
147
|
|
|
EBIT – Agricultural Productivity Segment
|
270
|
82
|
|||
|
EBIT– Total
|
490
|
229
|
|||
|
Interest Expense, Net
|
28
|
35
|
|||
|
Income Tax Provision(A)
|
123
|
68
|
|||
|
Net Income Attributable to Monsanto Company
|
$
|
339
|
$
|
126
|
|
|
(A)
|
Includes the income tax benefit on noncontrolling interest and the income tax provision on discontinued operations.
|
Reconciliation of EPS to Ongoing EPS: Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations.
|
Fiscal Year
|
Three months
|
Three months
|
|||||
|
2013
|
ended
|
ended
|
|||||
|
Guidance
|
Nov. 30, 2012
|
Nov. 30, 2011
|
|||||
|
Diluted Earnings per Share
|
$4.31-$4.41
|
$
|
0.63
|
$
|
0.23
|
||
|
Income on Discontinued Operations
|
(0.01)
|
(0.01)
|
—
|
||||
|
Diluted Earnings per Share from Ongoing Business
|
$4.30-$4.40
|
$
|
0.62
|
$
|
0.23
|
||
Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating activities and investing activities, as reflected in the Statements of Consolidated Cash Flows presented in this release. With respect to the fiscal year 2013 free cash flow guidance, Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing Activities because in order to prepare any such estimate or projection, Monsanto would need to rely on market factors and conditions that are outside of its control.
|
Fiscal Year
|
Three Months Ended
|
|||||
|
2013
|
Nov. 30,
|
|||||
|
Guidance
|
2012
|
2011
|
||||
|
Net Cash Provided by Operating Activities
|
$
|
2,900-3,300
|
$
|
1,569
|
$
|
1,110
|
|
Net Cash Required by Investing Activities
|
(1,100)-(1,300)
|
(96)
|
(254)
|
|||
|
Free Cash Flow
|
$
|
1,800-2,000
|
$
|
1,473
|
$
|
856
|
|
Net Cash Required by Financing Activities
|
N/A
|
(116)
|
(340)
|
|||
|
Effect of Exchange Rate Changes on Cash and Cash Equivalents
|
N/A
|
(3)
|
(81)
|
|||
|
Net Increase in Cash and Cash Equivalents
|
N/A
|
1,354
|
435
|
|||
|
Cash and Cash Equivalents at Beginning of Period
|
N/A
|
3,283
|
2,572
|
|||
|
Cash and Cash Equivalents at End of Period
|
N/A
|
$
|
4,637
|
$
|
3,007
|
|